Lidotral Five Percent With Menthol Liquid
NDC Package 59088-308-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lidotral Five Percent With Menthol (lidocaine hydrochloride, menthol) liquids is for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation. This formulation utilizes a liquid delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-308.

Identification & Billing

NDC Package Code
59088-308-03
Package Description
30 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
59088030803
RxNorm Crosswalk
  • RxCUI: 2667468 - lidocaine HCl 5 % / menthol 3 % Topical Spray
  • RxCUI: 2667468 - lidocaine hydrochloride 50 MG/ML / menthol 30 MG/ML Topical Spray

Clinical Specifications

Proprietary Name
Lidotral Five Percent With Menthol
Non-Proprietary Name
Lidocaine Hydrochloride, Menthol
Substance Name
Lidocaine Hydrochloride; Menthol
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
For the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation. This formulation can be used to assist patients in the treatment of mild to moderate acute or chronic aches or pain. Muscle or joint pain can be due to musculoligamentous strains, simple backache, tendonitis, osteoarthritis, rheumatoid arthritis, peripheral neuropathies such as diabetic neuropathy or post herpetic neuralgia, and other complex regional pains. If consulted by your physician, it may be used for other conditions as well. If consulted by your physician, it may be used for other conditions as well.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-06-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-308-03 identifies a specific commercial package of 30 ml in 1 bottle, spray of Lidotral Five Percent With Menthol, a human prescription drug labeled by Puretek Corporation. This liquid is formulated for topical use and contains lidocaine hydrochloride; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on October 06, 2023. The current certification is valid through December 31, 2026.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088030803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-308-03
11-Digit CMS (5-4-2)
59088-0308-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.